Take Solutions appoints Sunil Patra as MD and CFO

1 min read     Updated on 20 May 2026, 04:56 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

TAKE Solutions Limited has appointed Mr. Sunil Patra as Managing Director and Chief Financial Officer effective May 19, 2026. The five-year term requires shareholder approval within three months. Mr. Patra is a graduate experienced in operations and finance.

powered bylight_fuzz_icon
40778802

*this image is generated using AI for illustrative purposes only.

TAKE Solutions Limited has announced the appointment of Mr. Sunil Patra as the Managing Director and Chief Financial Officer of the company. The decision was taken during a Board Meeting held on Tuesday, May 19, 2026. The appointment is effective immediately from the same date.

Appointment Details

Mr. Sunil Patra has been appointed to the dual roles of Managing Director and Chief Financial Officer. The company has received a Certificate of Non-Debarment from Mr. Patra in connection with his appointment, confirming he is not debarred from holding the office of director by SEBI or any other authority.

Term and Conditions

The tenure for the position of Managing Director is set for a period of five years. However, this appointment is subject to the approval of the shareholders. The company must secure this approval at the next general meeting or within a period of three months from the date of appointment, whichever is earlier, in accordance with Regulation 17(1C) of SEBI LODR Regulations.

Profile of the Appointee

Mr. Sunil Patra is a graduate with professional experience in customer service operations and business coordination. His background includes handling operational and financial matters, managing customer relations, and overseeing administrative functions.

Particulars Details
Name Mr. Sunil Patra
DIN 11728362
Designation Managing Director & Chief Financial Officer
Date of Appointment May 19, 2026
Term Five years (subject to shareholder approval)

Historical Stock Returns for Take Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+1.47%+15.74%-38.48%-1.50%+201.42%-56.71%

How might Mr. Sunil Patra's background in customer service operations and business coordination influence TAKE Solutions' strategic direction, given the typically finance-heavy expectations of a CFO role?

What are the potential governance concerns for shareholders regarding the dual appointment of Managing Director and CFO in a single individual, and how might this affect the upcoming shareholder approval vote?

Who previously held the Managing Director and CFO positions at TAKE Solutions, and what circumstances led to this leadership transition?

TAKE Solutions seeks name change via postal ballot

6 min read     Updated on 19 May 2026, 11:01 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

TAKE Solutions Limited is seeking shareholder approval through a postal ballot to change its name to TAKE Limited, appoint M/s. A. Raghavendra Rao & Associates as statutory auditors, and amend the Memorandum of Association to include new business objects. The e-voting process commences on May 18, 2026, and concludes on June 16, 2026, for members registered as of May 08, 2026.

powered bylight_fuzz_icon
40227062

*this image is generated using AI for illustrative purposes only.

The Board of Directors of TAKE Solutions Limited has approved a proposal to change the company's name from "TAKE SOLUTIONS LIMITED" to "TAKE LIMITED", subject to member and regulatory approval. The decision was taken during a meeting held on Wednesday, May 13, 2026. The company has initiated a postal ballot process to seek shareholder consent for this name change, along with the appointment of a statutory auditor and amendments to the Memorandum of Association (MOA). The remote e-voting facility will be available from Monday, May 18, 2026, to Tuesday, June 16, 2026.

Key Resolutions

The postal ballot notice seeks member approval on four special businesses. The following table summarises the key resolutions:

Resolution Details
Name Change Change name from "TAKE SOLUTIONS LIMITED" to "TAKE LIMITED"
Statutory Auditor Appointment of M/s. A. Raghavendra Rao & Associates to fill casual vacancy
MOA Revision Adoption of new MOA aligned with Companies Act, 2013; merger of Clause III(C) into III(B)
Business Expansion Insertion of new object clauses for healthcare, pharmaceuticals, and biotechnology

Auditor Appointment and MOA Amendments

The board has appointed M/s. A. Raghavendra Rao & Associates, Chartered Accountants (FRN: 003324S, PRC No.: 018363), as Statutory Auditors to fill the casual vacancy caused by the resignation of M/s. Venkat and Rangaa LLP. The firm will hold office until the conclusion of the next Annual General Meeting in 2026.

Additionally, the board approved the adoption of a revised MOA to align with the Companies Act, 2013. This involves merging the existing Clause III(C) relating to "Other Objects" into Clause III(B), which pertains to Objects Incidental or Ancillary to the attainment of the Main Objects. The company also proposes to insert new object clauses to expand its business activities into healthcare technology, digital health solutions, diagnostics, pharmaceuticals, and biotechnology.

Postal Ballot and E-Voting Schedule

M/s. Hemang Satra & Associates, Practicing Company Secretaries (COP: 24235, PRC: 5684/2024), has been appointed as the Scrutinizer for the postal ballot process. The cut-off date for determining e-voting eligibility is Friday, May 08, 2026.

Parameter Details
Cut-off Date Friday, May 08, 2026
E-Voting Commencement Monday, May 18, 2026 (9:00 AM IST)
E-Voting Conclusion Tuesday, June 16, 2026 (5:00 PM IST)

The Scrutinizer's Report will be announced within two working days from the conclusion of the e-voting process. Members can cast their votes through remote e-voting or via postal ballot forms. The results will be displayed on the company's website and the websites of the stock exchanges.

Historical Stock Returns for Take Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+1.47%+15.74%-38.48%-1.50%+201.42%-56.71%

How might TAKE Limited's expansion into healthcare technology and life sciences impact its revenue mix and valuation multiples compared to its current IT solutions-focused business model?

Given that the previous statutory auditor M/s. Venkat and Rangaa LLP resigned citing audit fee constraints just weeks after appointment, what does this signal about TAKE Limited's financial governance and could it affect investor confidence going forward?

If members approve the MOA amendments enabling entry into diagnostics, biotechnology, and CRAMS sectors, what acquisition targets or strategic partnerships might TAKE Limited pursue to build capabilities in these capital-intensive domains?

More News on Take Solutions

1 Year Returns:+201.42%